Precigen, Inc. (PGEN) Revenue History
Precigen, Inc. (PGEN) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $81.06M |
| 2017-12-31 | $230.98M |
| 2018-12-31 | $151.18M |
| 2019-12-31 | $90.72M |
| 2020-12-31 | $103.18M |
| 2021-12-31 | $14.27M |
| 2022-12-31 | $26.91M |
| 2023-12-31 | N/A |
| 2024-12-31 | $3.92M |
| 2025-12-31 | $9.68M |
How PGEN compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| OCUL | Ocular Therapeutix Inc. | $51.95M |
| LXRX | Lexicon Pharmaceuticals Inc. | $49.80M |
| GOSS | Gossamer Bio Inc. | $48.47M |
| AQST | Aquestive Therapeutics Inc. | $44.55M |
| VSTM | Verastem Inc. | $30.91M |
These are five companies in the same sector as PGEN with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Precigen, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("PGEN", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | PGEN | $6.95 | -3.34% | 2.70M |
| 3 | ||||
| 4 | ||||
| 5 |